{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:16:04Z","timestamp":1720534564565},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":3371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/annonc\/mdq365","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T07:47:43Z","timestamp":1287474463000},"page":"vii334-vii338","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S7","title":["Genetic counselling for hereditary predisposition to ovarian and breast cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"J.","family":"Mackay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Szecsei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq365_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.37.3.203","article-title":"Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG)","volume":"37","author":"Eccles","year":"2000","journal-title":"J Med Genet"},{"key":"10.1093\/annonc\/mdq365_bb0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdq365_bb0020","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdq365_bb0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdq365_bb0030","series-title":"Textbook of Medical Oncology","first-page":"413","article-title":"Inherited predisposition to cancer","author":"Tischkowitz","year":"2004"},{"key":"10.1093\/annonc\/mdq365_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/096914130601300404","article-title":"The FH01 Management Committee Steering Committee and Collaborators. The challenge of evaluating annual mammography screening for young women with a family history of breast cancer","volume":"13","year":"2006","journal-title":"J Med Screen"},{"key":"10.1093\/annonc\/mdq365_bb0040","unstructured":"Lab21 Group http:\/\/www.lab21.com\/index.php (6 July 2010, date last accessed)"},{"key":"10.1093\/annonc\/mdq365_bb0045","unstructured":"Myriadhttp:\/\/www.myriad.com (6 July 2010, date last accessed)"},{"key":"10.1093\/annonc\/mdq365_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/BST0340633","article-title":"Cellular functions of the BRCA tumour-suppressor proteins","volume":"34","author":"Boulton","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1093\/annonc\/mdq365_bb0055","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly (ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1093\/annonc\/mdq365_bb0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coph.2006.02.004","article-title":"Inhibition of poly(ADP-ribose) polymerase in cancer","volume":"6","author":"Plummer","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1093\/annonc\/mdq365_bb0065","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1158\/1078-0432.CCR-07-4953","article-title":"Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin","volume":"14","author":"Evers","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdq365_bb0070","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1158\/0008-5472.CAN-08-2388","article-title":"Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2\/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin","volume":"69","author":"Matthews","year":"2009","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdq365_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Peter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq365_bb0080","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdq365_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdq365_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-08-0704","article-title":"Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer","volume":"18","author":"Mavaddat","year":"2009","journal-title":"Cancer Epidemiol Biomarkers"},{"key":"10.1093\/annonc\/mdq365_bb0095","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-08-3933","article-title":"The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdq365_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","article-title":"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment","volume":"97","author":"Jin","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq365_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clpt.2006.03.013","article-title":"Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment","volume":"80","author":"Borges","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/annonc\/mdq365_bb0110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2009.1420","article-title":"Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen","volume":"302","author":"Schroth","year":"2009","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdq365_bb0115","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrc2683","article-title":"CYP2D6 and tamoxifen: DNA matters in breast cancer","volume":"9","author":"Hoskins","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdq365_bb0120","first-page":"340","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdq365_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2472","article-title":"Gene expression profiling of peripheral blood cells for the early detection of breast cancer","volume":"12","author":"Aaroe","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mdq365_bb0130","article-title":"Blood test for breast cancer","author":"Halle","year":"2010","journal-title":"Sunday Express"},{"key":"10.1093\/annonc\/mdq365_bb0135","article-title":"Life saving blood test \u2018spots breast cancer early","author":"Martin","year":"2010","journal-title":"Daily Mail"},{"key":"10.1093\/annonc\/mdq365_bb0140","unstructured":"HPutlickNew test for cancer offered in Scotland. The Herald. (Glasgow 28 April 2010)"},{"key":"10.1093\/annonc\/mdq365_bb0145","unstructured":"Diagenic http:\/\/www.diagenic.com (6 July 2010, date last accessed)"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419397066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419397066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/suppl_7\/vii334\/19446307\/mdq365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T18:15:43Z","timestamp":1635790543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419397066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":28,"alternative-id":["S0923753419397066"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq365","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}